Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 15, 2023

BUY
$135.66 - $197.02 $206,067 - $299,273
1,519 Added 60.13%
4,045 $621,000
Q3 2022

Nov 07, 2022

BUY
$118.07 - $194.18 $298,244 - $490,498
2,526 New
2,526 $299,000

Others Institutions Holding MRNA

About Moderna, Inc.


  • Ticker MRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 391,200,000
  • Market Cap $15.5B
  • Description
  • Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...
More about MRNA
Track This Portfolio

Track Malaga Cove Capital, LLC Portfolio

Follow Malaga Cove Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Malaga Cove Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Malaga Cove Capital, LLC with notifications on news.